Chinese electric vehicle manufacturer XPeng Inc intends to sell 85 million American depositary shares (ADS) to raise up to $1.11 billion in its initial public offering (IPO) in New York.
Each ADS represents two Class A ordinary shares, priced between $11 and $13.
According to XPeng, existing investors Alibaba Group, Coatue, and Qatar Investment Authority had expressed interest in buying the ADSs of up to $200 million, $100 million and $50 million, respectively.
Xiaomi Corp also indicated an interest in purchasing up to $50 million of the ADSs.
US-listed Chinese companies are under tightened scrutiny and facing strict audit requirements from US regulators.
Alibaba is set to acquire all of XPeng’s class C ordinary shares, representing 14.9 percent of the voting power of all shares.
Another Chinese electric vehicle startup, Li Auto Inc LI.O, was able to raise $1.09 billion in its Nasdaq IPO last month.
The valuation of Guangzhou-based XPeng stood at $9.17 billion.
Founded in 2014, XPeng manufactures cars in two factories in China.


CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters 



